logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Patrick Schöffski

university hospitals leuven
H指数:93
被引数:4.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors

GPNMB导向的CAR T细胞疗法对抗MiT/TFE家族融合驱动型实体瘤

Nature Cancer
IF28.5
2026-07-010
PRE
Franz J. Zemp; Zackariah Breckenridge; Hyojin Song; Gurveer S. Gill; Taye L. Louie; Kiran Narta; Hongrui Liu; Yeon Suh; Louisa Guignard; Edna Ayerim Mandujano-Tinoco; Nicolás Collao; Joanna Pyczek; Kristofor K. Ellestad; Jada Curry; Jethro Langley; Cini John; Laura K. Mah; Jahanara Rajwani; Danyel Evseev; Madison Turk; Sacha Benaoudia; Jonathan Alex; Victor Naumenko; Varsha Thoppey Manoharan; Mobina Kazemi Mehrabadi; Harmony A. Smith; Geneece N. Y. Gilbert; Aaron Gillmor; Ted B. Verhey; Hayley M. Todesco; Katalin Osz; Bo-Young Ahn; Ana Bogossian; Colleen Anderson; Saif Sikdar; Shahrbano Rukunuddin; Tarek A. Bismar; Daniel Y. C. Heng; Keith Lawson; W. Marston Linehan; Haley Pedersen; Paul M. K. Gordon; John B. McIntyre; John MacGregor; Livia Garzia; Kathy Brodeur-Robb; Lisa DiFrancesco; Travis Ogilvie; Patrick Schöffski; Agnieszka Wozniak; Robert A. Holt; John Bell; Donna L. Senger; Victor Lewis; Michael Monument; Omar Khan; Lou Baudrier; Pierre Billon; Vincent Gabriel; Jeff Biernaskie; Kyle Potts; Kiril Trpkov; Kevin Hay; Jennifer Quizi; Jennifer Chan; Ramy Saleh; Jan Willem Henning; Nicole L. Prokopishyn; Mona Shafey; A. Sorana Morrissy; Douglas J. Mahoney
Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma

I期/ Ib期研究评估NIZ985单药治疗及联合抗PD-1药物在晚期实体瘤或淋巴瘤患者中的安全性、有效性、药代动力学和药效动力学

European Journal of Cancer
IF7.1
2026-06-240
PRE
Elena Garralda; Patrick Schöffski; Arjun Oberoi; Martin Schuler; Heike Richly; Paolo A. Ascierto; Chia-Chi Lin; Rosa Álvarez; Sandip Pravin Patel; Yan Xing; Vivek Subbiah; Nancy Lewis; Shonika Patel; Lydia Wang-L-akshman; Jong Bong Lee; Nadia B. Hassounah; Lang Ho Lee; Mike Roy; Souvik Banerjee; Aimee Reynolds
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study

Tazemetostat，一种EZH2抑制剂，在携带SWI/SNF突变的实体瘤中的II期篮式研究

Nature Communications
IF15.7
2026-03-250
OAAI
Mrinal Gounder; Patrick Schöffski; Robin L. Jones; Silvia Stacchiotti; George D. Demetri; Gregory M. Cote; Mark Agulnik; Rashmi Chugh; Thierry Jahan; Abha A. Gupta; Tom Wei-Wu Chen; Ravin Ratan; Palma Dileo; Alexander Drilon; Gabriel G. Malouf; Attila Szanto; Neal Gupta; Nizar M. Tannir
Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignancies

间质恶性肿瘤中尿激酶型纤溶酶原激活物受体相关蛋白（uPARAP）表达分子流行病学

Translational Oncology
IF4.1
2026-02-230
OAAI
Chao-Chi Wang; Pernille Barkholt; Agnieszka Wozniak; Ulla Vanleeuw; Che-Jui Lee; Luna De Sutter; Lore De Cock; Kimberly Verbeeck; Lars Henning Engelholm; Carmel Lynch; Dominik Mumberg; Patrick Schöffski
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors

晚期实体瘤患者AXL特异性抗体药物偶联物Enapotamab Vedotin的I/II期研究

Cancer Research Communications
IF0
2025-11-010
OA
Rohrberg, Kristoffer Staal; Lopez, Juanita S.; Milhem, Mohammed M.; Blank, Christian U.; Reijers, Irene; Thistlethwaite, Fiona; Plummer, Ruth; Piha-Paul, Sarina A.; Janne, Pasi A.; Shum, Elaine; Shaw, Heather M.; Debruyne, Philip R.; Lao, Cristopher; Baurain, Jean-Francois; Choe, Jennifer H.; Gort, Eelke; Zhao, Yujie; Jerusalem, Guy; Schoffski, Patrick; Chen, Andrew William; Cohen, Eric A.; Mankowski, Walter C.; Roshkovan, Leonid; Katz, Sharyn I.; Kontos, Despina; Brady, Lauren K.; Qutaish, Mohammed; Castro, Patricia Garrido; Pencheva, Nora; Bajaj, Gaurav; Fu, Yali; Windfeld, Kristian; Reiter, Panagiota; Jure-Kunkel, Maria; Higgs, Brandon W.; Amiri, Katayoun I.; Ahmadi, Tahamtan; Forssmann, Ulf; Ramalingam, Suresh S.; Vergote, Ignace
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter study

BOS172738，一种选择性RET抑制剂，用于治疗RET基因变异的肿瘤患者，包括RET融合阳性的非小细胞肺癌和RET突变型甲状腺髓样癌：一项多中心I期剂量递增/扩展研究

ESMO Open
IF8.3
2025-09-240
PREAI
P. Schöffski; A. Gazzah; J. Trigo; A. Italiano; P. Gougis; V. Subbiah; J.-Y. Shih; H.H. Loong; B. Doger; M. Keegan; B. Jeglinski; K. Andreas; B.C. Cho
Establishment of patient-derived 3D in vitro models of sarcomas: literature review and guidelines on behalf of the FORTRESS working group

建立来源于患者的肉瘤3D体外模型：文献综述和FORTRESS工作组指南

NEOPLASIA
IF7.7
2025-07-010
PRE
De Cock, Lore; Palubeckaite, Ieva; Bersani, Francesca; Faehling, Tobias; Pasquali, Sandro; Umbaugh, Sam; Meister, Michael Torsten; Danks, Molly R.; Manasterski, Piotr; Miallot, Richard; Krumbholz, Manuela; Roohani, Siyer; Heymann, Dominique; Cidre-Aranaz, Florencia; Wozniak, Agnieszka; Schoffski, Patrick; Bovee, Judith V. M. G.; Merlini, Alessandra; Venneker, Sanne
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma

新型溴结构域和-extra-terminal结构域抑制剂BI 894999在晚期实体瘤或弥漫性大B细胞淋巴瘤患者中的Ia/Ib期研究最终结果

ESMO OPEN
IF8.3
2025-05-010
PRE
Lauer, U. M.; Awada, A.; Postel-Vinay, S.; Shapiro, G. I.; Thieblemont, C.; Piha-Paul, S. A.; Paik, P. K.; Shepard, D. R.; Docampo, L. I.; Galot, R.; Rottey, S.; Sadrolhefazi, B.; Marzin, K.; Musa, H.; Schoffski, P.
Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II study of the EORTC Endocrine Task Force (protocol 1209-EnTF)
FRONTIERS IN ENDOCRINOLOGY
IF4.6
2024-06-271
OAAI
Leboulleux, Sophie; Kapiteijn, Ellen; Litiere, Saskia; Schoffski, Patrick; Godbert, Yann; Rodien, Patrice; Jarzab, Barbara; Salvatore, Domenico; Zanetta, Sylvie; Capdevila, Jaume; Bastholt, Lars; de la Fouchardiere, Christelle; Lalami, Yassine; Bardet, Stephane; Cornelis, Frank; Dedecjus, Marek; Links, Thera; Sents, Ward; Schlumberger, Martin; Locati, D. Laura; Newbold, Katie
Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours
JOURNAL OF PATHOLOGY CLINICAL RESEARCH
IF3.7
2024-05-131
OAAI
Baltazar, Rafael Zago; Claerhout, Sofie; Vander Borght, Sara; Spans, Lien; Sciot, Raphael; Schoffski, Patrick; Hompes, Daphne; Sinnaeve, Friedl; Wafa, Hazem; Renard, Marleen; van den Hout, Mari F. C. M.; Vernemmen, Astrid; Libbrecht, Louis; De Roo, An-Katrien; Mazzeo, Filomena; van Marcke, Cedric; Deraedt, Karen; Bourgain, Claire; Vanden Bempt, Isabelle
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent
CANCER
IF5.1
2024-03-122
OAAI
Gantzer, Justine; Toulmonde, Maud; Severac, Francois; Chamseddine, Ali N.; Charon-Barra, Celine; Vinson, Charles; Hervieu, Alice; Bourgmayer, Agathe; Bertucci, Francois; Ryckewaert, Thomas; Valentin, Thibaud; Firmin, Nelly; Chaigneau, Loic; Bompas, Emmanuelle; Follana, Philippe; Rioux-Leclercq, Nathalie; Soibinet-Oudot, Pauline; Bozec, Laurence; Le Loarer, Francois; Weingertner, Noelle; Chevreau, Christine; Duffaud, Florence; Blay, Jean-Yves; Kurtz, Jean-Emmanuel; Schoffski, Patrick; Brahmi, Mehdi; Malouf, Gabriel G.
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial

瑞替尼与舒尼替尼治疗胃肠道间质瘤: 3期临床试验的ctDNA生物标志物分析

NATURE MEDICINE
IF50
2024-01-0512
OAAI
Heinrich, Michael C.; Jones, Robin L.; George, Suzanne; Gelderblom, Hans; Schoeffski, Patrick; von Mehren, Margaret; Zalcberg, John R.; Kang, Yoon-Koo; Razak, Albiruni Abdul; Trent, Jonathan; Attia, Steven; Le Cesne, Axel; Siontis, Brittany L.; Goldstein, David; Boye, Kjetil; Sanchez, Cesar; Steeghs, Neeltje; Rutkowski, Piotr; Druta, Mihaela; Serrano, Cesar; Somaiah, Neeta; Chi, Ping; Reichmann, William; Sprott, Kam; Achour, Haroun; Sherman, Matthew L.; Ruiz-Soto, Rodrigo; Blay, Jean-Yves; Bauer, Sebastian
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
ONCOIMMUNOLOGY
IF6.3
2023-12-208
OA
Lin, Chia-Chi; Garralda, Elena; Schoeffski, Patrick; Hong, David S.; Siu, Lillian L.; Martin, Miguel; Maur, Michela; Hui, Rina; Soo, Ross A.; Chiu, Joanne; Zhang, Tian; Ma, Brigette; Kyi, Chrisann; Tan, Daniel S. W.; Cassier, Philippe A.; Sarantopoulos, John; Weickhardt, Andrew; Carvajal, Richard D.; Spratlin, Jennifer; Esaki, Taito; Rolland, Frederic; Akerley, Wallace; Deschler-Baier, Barbara; Rispoli, Lawrence; Samant, Tanay S.; Chowdhury, Niladri Roy; Gusenleitner, Daniel; Kwak, Eunice L.; Askoxylakis, Vasileios; De Braud, Filippo

研究方向

暂未获取到该数据
A
Agnieszka Woźniak
H 指数:46论文数:571被引数:7,533
J
Jean‐Yves Blay
H 指数:158论文数:2,395被引数:9.5万
R
Raf Sciot
H 指数:103论文数:1,054被引数:4.0万
M
Maria Dêbiec‐Rychter
H 指数:72论文数:708被引数:1.9万
H
Hans Gelderblom
H 指数:107论文数:1,321被引数:5.3万
S
Sebastian Bauer
H 指数:70论文数:966被引数:2.5万
R
Robin L. Jones
H 指数:92论文数:1,576被引数:3.6万
P
Piotr Rutkowski
H 指数:113论文数:1,764被引数:8.6万
P
Peter Reichardt
H 指数:84论文数:643被引数:3.4万
S
Silvia Stacchiotti
H 指数:86论文数:677被引数:2.5万